Direct NAD+ research
Early controlled research is testing whether specialized oral formulations can raise intracellular NAD+, while direct intravenous approaches are receiving closer tolerability study.
P—04 • Cellular coenzyme profile
NAD+
An essential cellular coenzyme connecting nutrient metabolism, mitochondrial energy production, redox balance, DNA repair, and stress-response signaling.
Name
NAD+
Nicotinamide adenine dinucleotide
- Scientific classification
- Vitamin B3-derived dinucleotide coenzyme and cellular redox cofactor
- Library family
- Metabolic
- Regulatory status
- No FDA-approved NAD+ treatment for wellness, energy enhancement, or healthy aging
Compound overview
A universal cellular energy carrier—and a growing focus of human research.
NAD+ is an essential coenzyme found in nearly every living cell. It is not a peptide. Cells continuously cycle it between NAD+ and NADH to move electrons through the reactions that turn nutrients into usable energy, especially within mitochondria.
NAD+ also acts as a working material for enzymes involved in DNA repair, gene regulation, cellular stress responses, inflammation, and communication between metabolism and the rest of the cell. This combination of energy transfer and enzyme signaling makes NAD+ central to many areas of modern biology.
Human research has increasingly focused on whether NAD+ levels can be restored through precursor compounds such as nicotinamide riboside and nicotinamide mononucleotide, or through direct NAD+ formulations. Trials consistently show that some approaches can change measured NAD+ or related metabolites, but the effect depends on the compound, delivery method, tissue, and measurement used.
Recent studies are beginning to move beyond measurement alone. A 2025 randomized single-center trial of intravenous NAD+ in people with ischemic heart failure reported an improvement in one heart-function measurement and encouraging trends in several secondary outcomes, while calling for larger multicenter confirmation. A separate 2025 trial found that nicotinamide riboside raised NAD+ in people with long COVID but did not significantly improve its main cognitive or symptom outcomes compared with placebo.
In 2026, early controlled research reported that a specialized oral NAD+ formulation increased intracellular whole-blood NAD+ over five days, while a small retrospective comparison of commercial intravenous NAD+ and nicotinamide riboside documented different infusion experiences and reinforced the need for stronger safety and effectiveness studies. The field is advancing, but meaningful clinical outcomes remain intervention-specific rather than guaranteed by a higher NAD+ measurement.
From levels to outcomes
Newer trials are asking whether changing NAD+ biology can influence meaningful measures in heart, neurological, metabolic, and age-related conditions.
Precision and translation
Future research must clarify which form reaches which tissue, how long changes last, and whether a laboratory measurement translates into a durable health outcome.
Mechanism under study
Redox chemistry and NAD+-dependent signaling
NAD+ transfers electrons during metabolism and is consumed by specialized enzymes, connecting cellular energy status with mitochondrial activity, DNA repair, and stress-response pathways.
Electron transfer
NAD+ accepts electrons during metabolic reactions and becomes NADH, helping maintain cellular redox balance.
Energy production
NADH transfers electrons to the mitochondrial respiratory chain, supporting the production of cellular ATP.
Enzyme signaling
Sirtuins, PARPs, and CD38 use NAD+, linking metabolism with gene regulation, DNA repair, and cellular stress responses.
NAD+ biology is established, but raising a measured NAD+ level does not by itself demonstrate improved health, performance, or longevity.
Current research areas
Questions under investigation
- How cells turn nutrients into energy
- How mitochondria maintain energy balance
- DNA repair and cellular stress responses
- How NAD+ changes with aging and disease
- Which restoration strategies produce meaningful human outcomes
Evidence summary
Established biology with emerging human evidence
- Cellular energy: NAD+ is required for the reactions that convert carbohydrates, fats, and proteins into usable energy.
- Redox balance: The NAD+/NADH cycle helps cells move electrons and keep metabolic reactions working efficiently.
- DNA repair: NAD+ supports enzymes that detect and respond to certain forms of cellular damage.
- Cellular communication: NAD+-dependent enzymes help coordinate stress responses, gene activity, immune signaling, and metabolic adaptation.
- Measurable restoration: Human trials show that several precursor and direct-formulation approaches can raise NAD+ or related metabolites in particular biological compartments.
- Clinical research opportunity: Early studies in selected medical conditions provide encouraging signals and a clearer roadmap for larger, longer, and more independent trials.
Raising a measured NAD+ level is an important biological finding, but it does not automatically establish improved energy, performance, disease outcomes, or longevity. Clinical meaning depends on the intervention and the outcome studied.
Educational notice
Education, not usage guidance.
This profile is provided for scientific education only. It is not medical advice, treatment guidance, dosing information, or instructions for NAD+ administration. Direct NAD+, nicotinamide riboside, nicotinamide mononucleotide, and other precursors are distinct interventions and should not be treated as interchangeable. The FDA has reported adverse events associated with compounded NAD+ injectable products and has warned about unsuitable ingredients being used in sterile preparations.
Key scientific referencesComing soon
A curated primary-source reference list will be added during the next educational expansion.